Geoffrey R. Oxnard

Jan 29, 2024 | brnw.ch | Shannon N. Westin |Judy E. Garber |Geoffrey R. Oxnard

Dr. Shannon Westin and her guests, Dr. Judy Garber and Dr. Geoffrey Oxnard, discuss the paper "Germline EGFR Mutations and Familial Lung Cancer" recently published in the JCO. TRANSCRIPTThe guest on this podcast episode has no disclosures to declare.  Shannon Westin:Hello, and welcome toJCO After Hours, the podcast where we get in-depth on articles that are published in theJournal of Clinical Oncology.

Jan 4, 2024 | physiciansweekly.com | Geoffrey R. Oxnard

Given its potential to impact health, physicians should not hesitate to refer families with a strong history of cancer for genetic counseling and testing. The past decades have produced huge advances in how physicians understand the genomics of lung cancer, explains Geoffrey Oxnard, MD. “Lung cancer in never-smokers is itself a common cancer, yet it has a distinct genetic fingerprint that makes it more amenable to targeted therapies and less amenable to immunotherapies,” he says.